Page results
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
UCLH has opened a new vaccine research centre with two clinical trials testing a long-acting antibody combination treatment to protect against Covid-19.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for patients receiving steroids for immunotherapy toxicity.
-
The palliative care team at UCLH provides specialist palliative and end-of-life care to any patient who has a life-limiting illness, and offers support to families and carers.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
UCLH is the London Cancer Centre for the surgical treatment of prostate cancer.
-
A combination of two drugs could be an effective treatment for the debilitating disease lupus, according to preliminary evidence from a UCLH led trial.
-
This page explains what sperm banking is, how it works and how it can benefit you.
File results
-
FOI/2024/0274 - Number of endoscopes at Trust
-
FOI/2024/0277 - Paediatric respiratory admission rates 2018-2023
-
FOI/2024/0279 - Social media management platforms and tools
-
FOI/2024/0283 - Cyber security/ cyber attack
-
FOI/2024/0285 - Private patient non-contractual tariffs
-
FOI/2024/0297 - Policy for parasitic infestation assessment and treatment of patients
-
FOI/2024/0302 - Mental health diagnosis for patients aged 11 to 25
-
FOI/2024/0301 - Nursing associates and trainee nursing associates policy
-
FOI/2024/0338 - Ophthalmology outpatient activity 2022, 2023 and 2024
-
FOI/2024/0295 - MRI scanners at Trust 2019/2020 and 2022/24